Ardelyx, Inc.
ARDXNASDAQHealthcare● Active
$5.54
$-0.02(-0.36%)
Market Cap$1.4B
P/E Ratio—
52W High$8.4
52W Low$3.49
Ardelyx, Inc. (ARDX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ARDX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
-$0.15
Est. -$0.13 · -15.4%
Revenue
$0.09B
Est. $0.09B · +1.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
ARDX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | -$0.02 | — | — | — | $0.13B | — |
| ▼ Q2 FY2026 | Apr 30, 2026 | -$0.13 | -$0.15 | -15.4% | $0.09B | $0.09B | +1.8% |
| — Q1 FY2026 | Feb 19, 2026 | $0.02 | $0.02 | +0.0% | $0.13B | $0.12B | +6.1% |
| ▲ Q4 FY2025 | Oct 30, 2025 | -$0.06 | -$0.00 | +93.3% | $0.11B | $0.12B | -7.3% |
| ▲ Q3 FY2025 | Aug 4, 2025 | -$0.13 | -$0.08 | +38.5% | $0.10B | $0.09B | +3.2% |
| ▼ Q2 FY2025 | May 1, 2025 | -$0.10 | -$0.17 | -70.0% | $0.07B | $0.08B | -6.7% |
| — Q1 FY2025 | Feb 20, 2025 | $0.02 | $0.02 | +0.0% | $0.12B | $0.07B | +55.8% |
| ▲ Q4 FY2024 | Oct 31, 2024 | -$0.05 | -$0.00 | +93.1% | $0.10B | $0.11B | -9.5% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Miss
EPS Actual
-$0.15
EPS Est.
-$0.13
EPS Surpr.
-15.4%
Revenue
$0.09B
Q1 FY2026
Feb 19, 2026
EPS Actual
$0.02
EPS Est.
$0.02
EPS Surpr.
+0.0%
Revenue
$0.13B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
-$0.00
EPS Est.
-$0.06
EPS Surpr.
+93.3%
Revenue
$0.11B
Q3 FY2025
Aug 4, 2025Beat
EPS Actual
-$0.08
EPS Est.
-$0.13
EPS Surpr.
+38.5%
Revenue
$0.10B
Q2 FY2025
May 1, 2025Miss
EPS Actual
-$0.17
EPS Est.
-$0.10
EPS Surpr.
-70.0%
Revenue
$0.07B
Q1 FY2025
Feb 20, 2025
EPS Actual
$0.02
EPS Est.
$0.02
EPS Surpr.
+0.0%
Revenue
$0.12B
Q4 FY2024
Oct 31, 2024Beat
EPS Actual
-$0.00
EPS Est.
-$0.05
EPS Surpr.
+93.1%
Revenue
$0.10B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.23 | $0.24 | $0.25 | 2 |
| Q3 FY2027 | $0.16 | $0.16 | $0.17 | 2 |
| Q2 FY2027 | $0.08 | $0.08 | $0.08 | 2 |
| Q1 FY2027 | $-0.06 | $-0.06 | $-0.06 | 2 |
| Q4 FY2026 | $0.09 | $0.09 | $0.10 | 4 |
| Q3 FY2026 | $0.01 | $0.04 | $0.07 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 3 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 3 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 3 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 4 |
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 4 |
| Q3 FY2026 | $0.1B | $0.2B | $0.2B | 7 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 30, 2026 | -15.4% | $6.01 | $6.33 | +5.32% |
| ▲ Q1 FY2026 | Feb 19, 2026 | +0.0% | $6.72 | $6.74 | +0.30% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +93.3% | $4.96 | $5.01 | +1.01% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +38.5% | $4.33 | $4.39 | +1.39% |
| ▼ Q2 FY2025 | May 1, 2025 | -70.0% | $5.51 | $5.47 | -0.73% |
| ▲ Q1 FY2025 | Feb 20, 2025 | +0.0% | $6.36 | $5.72 | -10.06% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +93.1% | $5.89 | $5.87 | -0.34% |
| ▲ Q3 FY2024 | Aug 1, 2024 | +30.0% | $5.55 | $5.50 | -0.90% |
Q2 FY2026+5.32%
Report Date
Apr 30, 2026
EPS Beat/Miss
-15.4%
Price Before
$6.01
Price After
$6.33
Q1 FY2026+0.30%
Report Date
Feb 19, 2026
EPS Beat/Miss
+0.0%
Price Before
$6.72
Price After
$6.74
Q4 FY2025+1.01%
Report Date
Oct 30, 2025
EPS Beat/Miss
+93.3%
Price Before
$4.96
Price After
$5.01
Q3 FY2025+1.39%
Report Date
Aug 4, 2025
EPS Beat/Miss
+38.5%
Price Before
$4.33
Price After
$4.39
Q2 FY2025-0.73%
Report Date
May 1, 2025
EPS Beat/Miss
-70.0%
Price Before
$5.51
Price After
$5.47
Q1 FY2025-10.06%
Report Date
Feb 20, 2025
EPS Beat/Miss
+0.0%
Price Before
$6.36
Price After
$5.72
Q4 FY2024-0.34%
Report Date
Oct 31, 2024
EPS Beat/Miss
+93.1%
Price Before
$5.89
Price After
$5.87
Q3 FY2024-0.90%
Report Date
Aug 1, 2024
EPS Beat/Miss
+30.0%
Price Before
$5.55
Price After
$5.50
Avg Beat Reaction-1.43%
Avg Miss Reaction+2.29%
Beat Rate6 / 8 quarters
Largest Move-10.06% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ARDX ends December
Ardelyx, Inc. (ARDX) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $-0.15 — missing the analyst consensus of $-0.13 by -15.4%. The next ARDX earnings date is expected around September 1, 2026.
Each quarter, investors track ARDX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARDX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ARDX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ARDX earnings · 5 questionsArdelyx, Inc.'s next earnings report is expected around September 1, 2026. ARDX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARDX historically reports after market close (AMC).
ARDX earnings datewhen is ARDX earningsARDX next earnings datewhen does ARDX report earningsARDX earnings calendar
▸ Source: FMP · Ardelyx, Inc. SEC filings · US GAAP · Ardelyx, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026